LeukoStrat CDx FLT3 Mutation Assay

Requisition Form: Requisition Form

The Leukostrat CDx FLT3 Mutation Assay is designed to detect internal tandem duplications and tyrosine kinase mutations (TKD) in the FLT3 gene. The Leukostrat CDx FLT3 Mutation Assay is the only in vitro diagnostic assay authorized by the FDA for AML patients.

LeukoStrat_FLT3_desc.pdf

Na Heparin Whole Blood or Na Heparin Bone Marrow

Specimens can be stored at 2-8 C for up to 7 days prior to testing. Do not freeze. Frozen samples are not acceptable.

Cold Pack (2-8C)

2 ml Na Heparin Whole Blood or 0.5 ml Na Heparin Bone Marrow

1 ml Na Heparin Whole Blood or 0.25 ml Na Heparin Bone Marrow

0023U, 0046U

PCR and Capillary Electrophoresis

5-7 days

Approved